The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sara,Monti

第一单位： Rheumatology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

作者： Sara,Monti ^[1] ; Paolo,Delvino ^[2] ; Mattia,Riboli ^[1] ; Chiara,Rebuffi ^[2] ; Blerina,Xoxi ^[3] ; Annalisa,De Silvestri ^[4] ; Carlomaurizio,Montecucco ^[1]

作者单位： Rheumatology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. ^[1] PhD in Experimental Medicine, University of Pavia, Pavia, Italy. ^[2] Università degli Studi di Milano Bicocca-Scuola di specializzazione medica in medicina fisica e Riabilitativa, Milan, Italy. ^[3] Scientific Direction, Grant Office and Scientific Documentation Center, Pavia, Italy. ^[4] Biometry and Clinical Epidemiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. ^[5]

关键词 anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis co-trimoxazole granulomatosis with polyangiitis infections pneumocystis jirovecii relapse trimethoprim/sulfametoxazole

主题词抗菌药(Anti-Bacterial Agents);抗中性粒细胞胞浆抗体相关性血管炎(Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis);人类(Humans);二级预防(Secondary Prevention)

DOI 10.1093/rheumatology/keab267

PMID 33752235

发布时间 2021-08-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交